These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3255817)

  • 1. Screening for coronary heart disease risk factors.
    Aylett M; Gray D
    J R Coll Gen Pract; 1988 Jun; 38(311):274-5. PubMed ID: 3255817
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical inquiries. When should we screen children for hyperlipidemia?
    Misicko NE; St Anna L; Foliaco W
    J Fam Pract; 2006 Aug; 55(8):723-5. PubMed ID: 16882449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart disease.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1987; 117():167-73. PubMed ID: 2977686
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial combined hyperlipidemia. II. Risk of ischemic heart disease].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):887-93. PubMed ID: 3765426
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipoproteinemias in childhood].
    Widhalm K
    Wien Med Wochenschr; 1994; 144(12-13):320-3. PubMed ID: 8650937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of risk factors for coronary heart disease among attenders and non-attenders at a screening programme.
    Jones A; Cronin PA; Bowen M
    Br J Gen Pract; 1993 Sep; 43(374):375-7. PubMed ID: 8251234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperlipidemia in children].
    Skovby F; Dyerberg J; Faergeman O; Haghfelt T; Jensen TJ; Leth A; Sigurd B; Stender S; Vittrup MA
    Ugeskr Laeger; 1993 Mar; 155(11):810-4. PubMed ID: 8460436
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol and coronary heart disease: screening and treatment.
    Turner-Boutle M
    Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for coronary heart diseases in male industrial employees--results of a screening study in 2 large North German industries].
    Helmert U; Groetschel R; Herman B; Klesse R; Greiser E
    Offentl Gesundheitswes; 1986 May; 48(5):249-54. PubMed ID: 2941712
    [No Abstract]   [Full Text] [Related]  

  • 13. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
    Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional status of the cardiovascular system in persons with risk factors for ischemic heart disease].
    Gembitskiĭ EV; Kondrakov VM
    Sov Med; 1985; (8):93-6. PubMed ID: 4059995
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventive nutrition intervention in coronary heart disease: risk assessment and formulating dietary goals.
    Posner BM; DeRusso PA; Norquist SL; Erick MA
    J Am Diet Assoc; 1986 Oct; 86(10):1395-401. PubMed ID: 3760431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the value of mass screening for coronary risks.
    Leaman DM; Crawshaw SL; Zelis RF
    Pa Med; 1981 Feb; 84(2):29-31. PubMed ID: 6785708
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should persons with increased risk of coronary disease be identified?].
    Damsbo N
    Ugeskr Laeger; 1996 Aug; 158(34):4777. PubMed ID: 8801689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.